Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 860150 | ISIN: US1910981026 | Ticker-Symbol: CC5
Frankfurt
15.01.25
08:03 Uhr
1.250,00 Euro
0,00
0,00 %
1-Jahres-Chart
COCA-COLA CONSOLIDATED INC Chart 1 Jahr
5-Tage-Chart
COCA-COLA CONSOLIDATED INC 5-Tage-Chart
RealtimeGeldBriefZeit
1.250,001.260,0009:58
1.250,001.260,0009:30
GlobeNewswire (Europe)
8.200 Leser
Artikel bewerten:
(2)

Coca-Cola Consolidated, Inc.: Coca-Cola Consolidated CFO Scott Anthony to Retire, Company Names Matt Blickley as New CFO

Finanznachrichten News

CHARLOTTE, N.C., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (NASDAQ: COKE) announced today that Executive Vice President and Chief Financial Officer (CFO), Scott Anthony, will retire effective March 31, 2025. Mr. Anthony has served as the Company's CFO since 2018.

The Company also announced that Matthew J. Blickley will assume the role of Executive Vice President and Chief Financial Officer, effective April 1, 2025. Mr. Blickey joined Coca-Cola Consolidated in 2014 and currently serves as Senior Vice President, Financial Planning and Chief Accounting Officer. He will continue to serve as the Company's Chief Accounting Officer following this change. During his tenure with the Company, Mr. Blickley has served in a variety of financial roles of increasing responsibility, including Corporate Controller. He is a certified public accountant and began his career with PricewaterhouseCoopers LLP. Mr. Blickley will serve on the Company's executive leadership team and will report to Dave Katz, President and Chief Operating Officer.

"We are grateful for Scott's significant contributions over the past six years," said J. Frank Harrison, III, Chairman and Chief Executive Officer. "Scott's deep experience within the Coca-Cola system and strategic leadership were instrumental in our ability to deliver the exceptional financial performance and strong stockholder returns we've achieved since 2019. His work in developing talent, evolving our financial systems and his partnership with our business leaders has been invaluable. I want to thank Scott for his commitment to the succession planning process, and we appreciate Scott staying engaged with the Company in a consultancy role following his retirement."

"I am very pleased to have Matt Blickley succeed Scott as CFO, reflecting our depth of talent and careful succession planning," said Dave Katz, President and Chief Operating Officer. "I've worked closely with Matt over the past decade, and I am confident he is the right leader to take on this important role and continue to deliver on our Purpose, culture and financial success."

CONTACTS:
Brian K. Little (Media)Scott Anthony (Investors)
Vice President, Corporate Communications OfficerExecutive Vice President & Chief Financial Officer
(980) 378-5537(704) 557-4633
Brian.Little@cokeconsolidated.comScott.Anthony@cokeconsolidated.com

About Coca-Cola Consolidated, Inc.

Headquartered in Charlotte, N.C., Coca-Cola Consolidated (NASDAQ: COKE) is the largest Coca-Cola bottler in the United States. We make, sell and distribute beverages of The Coca-Cola Company and other partner companies in more than 300 brands and flavors across 14 states and the District of Columbia, to approximately 60 million consumers. For over 122 years, we have been deeply committed to the consumers, customers and communities we serve and passionate about the broad portfolio of beverages and services we offer. Our Purpose is to honor God in all we do, to serve others, to pursue excellence and to grow profitably.

More information about the Company is available at www.cokeconsolidated.com. Follow Coca-Cola Consolidated on Facebook, X, Instagram and LinkedIn.


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.